NOVACYT HALF YEAR 2018 RESULTS Molecular product revenues up 18% to €3m Gross margin increases to 64%

Novacyt half year 2018 results

Paris, France and Camberley, UK – 26 September 2018 – Novacyt (ALTERNEXT: ALNOV; AIM: NCYT), an international specialist in clinical diagnostic products, today announces unaudited financial results for the six months ended 30 June 2018.